News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Labopharm (DDS.TO) Adds Russia To Distribution And Licensing Agreement With CSC Pharmaceuticals Handels GmbH For Once-Daily Tramadol



10/19/2005 5:12:55 PM

LAVAL, QC, March 3 /CNW/ - Labopharm Inc. (TSX: DDS) today announced that its European subsidiary, Labopharm Europe Limited, has amended its licensing and distribution agreement with Austria-based CSC Pharmaceuticals Handels GmbH for once-daily tramadol to include Russia. The amendment increases the number of countries covered by the agreement to 15.

Read at Canada NewsWire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES